Introduction:
BD expands operations with US$4.3 million (€4 million) R&D Centre in Dublin and US$32 million (€30) million investment in Enniscorthy manufacturing plant in Ireland.
Features:
The new facility will be dedicated to advancing inaugural on-body injector device, the BD Evolve™ On-Body Injector, aligning with the growing demand for injectable drugs in the pharmaceutical pipeline.
The new 10,600 sq. ft. R&D facility in Blackrock, accommodating 35 high-tech employees, complements the existing Limerick R&D centre with over 300 personnel.
Additionally, it will function as the regional hub for sales, technical service, and corporate functional support teams.
Furthermore, it also expands its operations with a 40,000 sq. ft. facility to manufacture a new medical technology from the Peripheral Intervention business unit. These dual investments will result in the creation of more than 85 new employment opportunities.
Specifications:
Name Becton Dickinson
Type New Construction
Budget US$4.3 million (€4 million) R&D Centre & US$32 million (€30) million Manufacturing Plant
